We are live on ! Find out more
SAM

Simplify Asset Management Portfolio holdings

AUM $7.19B
1-Year Est. Return 6.88%
This Fund
S&P 500
This Quarter Est. Return
-1.08%
1 Year Est. Return
+6.88%
3 Year Est. Return
+44.98%
5 Year Est. Return
+50.08%
10 Year Est. Return
–
AUM
$6.52B
AUM Growth
+$390M
Cap. Flow
+$493M
Cap. Flow %
7.57%
Top 10 Hldgs %
93.82%
Holding
176
New
34
Increased
22
Reduced
73
Closed
33

Top Buys

1
SBIL
Simplify Government Money Market ETF
SBIL
+$239M
2
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$130M
3
TUA icon
Simplify Short Term Treasury Futures Strategy ETF
TUA
+$120M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$56.1M
5
BUCK icon
Simplify Stable Income ETF
BUCK
+$40.3M

Top Sells

1
UNH icon
UnitedHealth
UNH
+$28.9M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$15.5M
3
APLS
Apellis Pharmaceuticals
APLS
+$13.5M
4
AMGN icon
Amgen
AMGN
+$13M
5
LLY icon
Eli Lilly
LLY
+$11.4M

Sector Composition

1 Healthcare 3.66%
2 Energy 0.49%
3 Industrials 0.27%
4 Technology 0.18%
5 Real Estate 0.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VOR icon
76
Vor Biopharma
VOR
$940M
$955K 0.01%
+53,510
New +$755K
ZVRA icon
77
Zevra Therapeutics
ZVRA
$754M
$938K 0.01%
100,630
+58,265
+138% +$525K
OBIO icon
78
Orchestra BioMed
OBIO
$223M
$932K 0.01%
+219,387
New +$934K
ARR
79
Armour Residential REIT
ARR
$2.12B
$899K 0.01%
53,900
-24,100
-31% -$426K
FULC icon
80
Fulcrum Therapeutics
FULC
$233M
$890K 0.01%
115,994
-43,680
-27% -$405K
CMPS
81
Compass Pathways
CMPS
$1.68B
$880K 0.01%
159,052
-130,948
-45% -$881K
XOM icon
82
ExxonMobil
XOM
$605B
$826K 0.01%
4,871
-2,987
-38% -$436K
MRK icon
83
Merck
MRK
$315B
$787K 0.01%
+6,544
New +$756K
UNH icon
84
UnitedHealth
UNH
$384B
$785K 0.01%
2,901
-96,906
-97% -$28.9M
TRVI icon
85
Trevi Therapeutics
TRVI
$2.46B
$780K 0.01%
+65,412
New +$732K
MA icon
86
Mastercard
MA
$487B
$762K 0.01%
1,526
-169
-10% -$89K
OCUL icon
87
Ocular Therapeutix
OCUL
$2.01B
$762K 0.01%
+90,000
New +$858K
QCOM icon
88
Qualcomm
QCOM
$180B
$718K 0.01%
5,574
+171
+3% +$25K
SABS icon
89
SAB Biotherapeutics
SABS
$280M
$717K 0.01%
187,230
-20,997
-10% -$83.7K
COO icon
90
Cooper Companies
COO
$14.3B
$711K 0.01%
9,942
-3,700
-27% -$293K
BSX icon
91
Boston Scientific
BSX
$66.3B
$711K 0.01%
11,324
-4,227
-27% -$338K
UPB
92
Upstream Bio Inc
UPB
$393M
$700K 0.01%
+77,793
New +$1.4M
FDMT icon
93
4D Molecular Therapeutics
FDMT
$567M
$656K 0.01%
+70,430
New +$613K
CIM
94
Chimera Investment
CIM
$1.1B
$640K 0.01%
51,025
– –
PANW icon
95
Palo Alto Networks
PANW
$289B
$636K 0.01%
+3,967
New +$666K
PALI icon
96
Palisade Bio
PALI
$328M
$613K 0.01%
+350,000
New +$636K
INTU icon
97
Intuit
INTU
$80.6B
$612K 0.01%
1,416
-52
-4% -$24.8K
NOW icon
98
ServiceNow
NOW
$107B
$567K 0.01%
5,421
-508
-9% -$59.8K
SYK icon
99
Stryker
SYK
$127B
$562K 0.01%
1,710
-624
-27% -$224K
ADBE icon
100
Adobe
ADBE
$93.5B
$551K 0.01%
+2,266
New +$628K
2 3
4
5 6

Similar funds

CFG
Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $7.18B AUM 21.21% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.17B AUM 17.27% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
UB
UMB Bank Kansas City, Missouri $7.16B AUM 20.88% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
FPA
First Pacific Advisors El Segundo, California $7.14B AUM 21.51% 1-Year Est. Return
SC
Saturna Capital Bellingham, Washington $7.13B AUM 35.47% 1-Year Est. Return

Simplify Asset Management's Q1 2026 Portfolio in Review

As of Q1 2026, Simplify Asset Management held 176 positions worth $6.52B, up 6.4% from $6.13B the previous quarter. Its ten largest holdings account for 94% of the portfolio.

Simplify Asset Management deployed $493M of net new capital in Q1 2026, opening 34 new positions and adding to 22 existing holdings. Its largest new stake was Simplify Short Term Treasury Futures Strategy ETF: 5,528,700 shares worth $117M.

By sector, the portfolio is most concentrated in Healthcare at 3.7% of assets, down from 5.8% a quarter earlier, followed by Energy and Industrials.

On the sell side, the largest reduction was UnitedHealth, an estimated $28.9M trimmed.

  • Simplify Asset Management's largest Q1 2026 buy was Simplify Short Term Treasury Futures Strategy ETF: 5,528,700 shares worth $117M.
  • Simplify Asset Management added most to Simplify Government Money Market ETF in Q1 2026, an estimated $239M increase.
  • Simplify Asset Management's biggest Q1 2026 reduction was UnitedHealth, cutting an estimated $28.9M.
  • Simplify Asset Management fully exited Apellis Pharmaceuticals in Q1 2026, selling an estimated $13.5M.
  • Simplify Asset Management's ten largest holdings make up 94% of its $6.52B portfolio in Q1 2026.
  • Simplify Asset Management opened 34 new positions and closed 33 in Q1 2026.
  • Simplify Asset Management's portfolio value rose 6.4% quarter-over-quarter to $6.52B.

Based on Simplify Asset Management's 13F filing for Q1 2026, filed 27 Apr 2026.